Zhejiang Wolwo Bio-pharmaceutical Co.,Ltd is a listed high-tech biopharmaceutical company (stock code: 300357). Dedicated to developing innovative drugs with significant technological or market advantages (including promising drugs with definite curative effects or natural drugs / stem cell drugs) or products including innovative medical devices with similar medical efficacies, Wolwo’s basic product development strategy is to obtain leading market position through independent R&D, investment or M&A of technologies, products or enterprises that meets the aforesaid standard and enjoys IP protection.
Our core values: commitment, strong execution, personal responsibility
Commitment is not only our requirement, but also our promise to ensure that the company can achieve its mission and that each member can obtain sustainable development and returns from the company.
Strong execution is the ability to make things happen, which is the key for an organization to fulfill its mission.